Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
August 24, 2000
Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity
E W Wang, B M Kessler, A Borodovsky, et al.
The European Journal of Neuroscience
|
July 6, 2004
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala
A I Gulyas, B F Cravatt, M H Bracey, et al.
The Journal of Cell Biology
|
February 7, 1998
The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells
X Guan, B F Cravatt, G R Ehring, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 18, 1999
Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition
D L Boger, H Sato, A E Lerner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 27, 2001
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
B F Cravatt, K Demarest, M P Patricelli, et al.
Science (New York, N.Y.)
|
June 9, 1995
Chemical characterization of a family of brain lipids that induce sleep
B F Cravatt, O Prospero-Garcia, G Siuzdak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 30, 2013
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors
G Pryce, A Cabranes, J Fernández-Ruiz, et al.
Analytical Chemistry
|
March 15, 2005
Desorption/ionization on silicon nanowires
E P Go, J V Apon, G Luo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 9, 2009
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain
S G Kinsey, J Z Long, S T O'Neal, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 15, 2020
The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain
A L Thompson, S A Grenald, H A Ciccone, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Proceedings of the National Academy of Sciences of the United States of America
|
August 24, 2000
Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity
E W Wang, B M Kessler, A Borodovsky, et al.
The European Journal of Neuroscience
|
July 6, 2004
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala
A I Gulyas, B F Cravatt, M H Bracey, et al.
The Journal of Cell Biology
|
February 7, 1998
The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells
X Guan, B F Cravatt, G R Ehring, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 18, 1999
Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition
D L Boger, H Sato, A E Lerner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 27, 2001
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
B F Cravatt, K Demarest, M P Patricelli, et al.
Science (New York, N.Y.)
|
June 9, 1995
Chemical characterization of a family of brain lipids that induce sleep
B F Cravatt, O Prospero-Garcia, G Siuzdak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 30, 2013
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors
G Pryce, A Cabranes, J Fernández-Ruiz, et al.
Analytical Chemistry
|
March 15, 2005
Desorption/ionization on silicon nanowires
E P Go, J V Apon, G Luo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 9, 2009
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain
S G Kinsey, J Z Long, S T O'Neal, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 15, 2020
The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain
A L Thompson, S A Grenald, H A Ciccone, et al.
Page
of 5